Medicine & Life Sciences
Angiotensin II
29%
Biosensing Techniques
10%
Blood Pressure
6%
Brain Natriuretic Peptide
9%
Calcium-Calmodulin-Dependent Protein Kinase Type 2
66%
Calcium-Calmodulin-Dependent Protein Kinases
65%
Cardiac Arrhythmias
6%
Cardiac Myocytes
96%
Cardiomegaly
36%
Cardiovascular System
10%
Cyclic GMP-Dependent Protein Kinase Type I
15%
Diet
35%
Disease Progression
8%
Drug Therapy
11%
Fish Oils
63%
Fluorescence Resonance Energy Transfer
69%
Guanosine Monophosphate
77%
Guanylate Cyclase
12%
Heart
20%
Heart Failure
6%
Hypertrophy
47%
Investigational Therapies
12%
Left Ventricular Hypertrophy
55%
Ligands
7%
Muscle Cells
15%
Myosin Heavy Chains
10%
NADPH Oxidases
19%
Natriuretic Peptides
12%
Nitric Oxide
42%
Nitric Oxide Donors
12%
Nitrites
9%
nitroxyl
84%
Omega-3 Fatty Acids
8%
Oxidation-Reduction
8%
oxyhyponitrite
100%
p38 Mitogen-Activated Protein Kinases
8%
Phosphodiesterase Inhibitors
12%
Phosphorylation
8%
Pressure
7%
Reperfusion
17%
Soluble Guanylyl Cyclase
66%
Standard of Care
10%
Superoxides
52%
Therapeutics
11%
Transgenic Mice
24%
Unsaturated Dietary Fats
78%
Unsaturated Fatty Acids
17%
Vasodilation
8%
vasodilator-stimulated phosphoprotein
13%
Ventricular Remodeling
12%
Agriculture & Biology
angiotensin II
29%
cardiomyocytes
63%
cardiovascular diseases
9%
cGMP-dependent protein kinase
12%
death
6%
drug therapy
8%
guanylate cyclase
64%
heart failure
12%
hypertrophy
55%
mitogen-activated protein kinase
9%
myosin heavy chains
10%
NAD(P)H oxidase (H2O2-forming)
20%
natriuretic peptides
12%
neonates
7%
nitrites
8%
phosphoproteins
10%
phosphorylation
7%
protein synthesis
6%
risk factors
8%
salts
29%
sodium
6%
superoxide anion
48%
therapeutics
6%
vasodilation
10%
vasodilator agents
10%